The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018

The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018 Infection (2018) 46:289–291 https://doi.org/10.1007/s15010-018-1142-4 EDITORIAL The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018 Johannes R. Bogner Published online: 7 May 2018 © Springer-Verlag GmbH Germany, part of Springer Nature 2018 This year’s ECCMID in Madrid convened roughly 13,000 patients in developed countries) flucloxacillin is not suffi- professionals to hear and discuss about 3500 contributions cient to result in sufficient clinical improvement by day 6. in more than 200 sessions, most of them in parallel. The Moreover, in both groups only roughly 50% reached clinical field was covered extensively in all aspects from infections cure opening the question, whether flucloxacillin can remain control over clinical microbiology, clinical infection man- the suggested first line option for cellulitis (O 1122 [3 ]). agement through vaccination and other preventive measures. A putative “DEAD box RNA helicase” gene “help”s One contribution of the European Centre for Disease Pseudomonas to be a killer: By sequencing and establishing and Prevention Control (ECDC) by Dr. Robesyn summa- a phylogenetic analysis of the core and accessory genome of rized clinical characteristics of all 37,365 cases of measles pseudomonas strains from blood stream infections a micro- reported to the ECDC from 2013 to 2017, 81% occurring biology http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Infection Springer Journals

The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018

Loading next page...
 
/lp/springer_journal/the-field-is-moving-on-new-diagnostic-and-therapeutic-tools-presented-T6XbAuabHh
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Medicine & Public Health; Infectious Diseases; General Practice / Family Medicine; Internal Medicine
ISSN
0300-8126
eISSN
1439-0973
D.O.I.
10.1007/s15010-018-1142-4
Publisher site
See Article on Publisher Site

Abstract

Infection (2018) 46:289–291 https://doi.org/10.1007/s15010-018-1142-4 EDITORIAL The field is moving on: new diagnostic and therapeutic tools presented at the 28th ECCMID 2018 Johannes R. Bogner Published online: 7 May 2018 © Springer-Verlag GmbH Germany, part of Springer Nature 2018 This year’s ECCMID in Madrid convened roughly 13,000 patients in developed countries) flucloxacillin is not suffi- professionals to hear and discuss about 3500 contributions cient to result in sufficient clinical improvement by day 6. in more than 200 sessions, most of them in parallel. The Moreover, in both groups only roughly 50% reached clinical field was covered extensively in all aspects from infections cure opening the question, whether flucloxacillin can remain control over clinical microbiology, clinical infection man- the suggested first line option for cellulitis (O 1122 [3 ]). agement through vaccination and other preventive measures. A putative “DEAD box RNA helicase” gene “help”s One contribution of the European Centre for Disease Pseudomonas to be a killer: By sequencing and establishing and Prevention Control (ECDC) by Dr. Robesyn summa- a phylogenetic analysis of the core and accessory genome of rized clinical characteristics of all 37,365 cases of measles pseudomonas strains from blood stream infections a micro- reported to the ECDC from 2013 to 2017, 81% occurring biology

Journal

InfectionSpringer Journals

Published: May 7, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off